In this issue:
Urate-lowering therapy improves HRQOL and work productivity
TNFi + csDMARD comedication: no benefit in SpA
Reducing TNFi dose in AS and PsA
The hidden burden of AS in the community
Fatigue does not resolve in many RA patients
High-intensity statin treatment reduces risk of RA?
Tophi drive the erosive process in gout
Good response on TNFi lowers CVD risk in RA
Cancer risk assessed in SpA treated with TNFi
Please login below to download this issue (PDF)